Abstract: The present invention relates to a driving structure for use in an optical actuator, including: a first driving part, which is suitable for mounting a lens and driving the lens to move transversely in the x-axis and y-axis directions; and a second driving part, which is suitable for driving a photosensitive chip to move transversely in the x-axis and y-axis directions, where the lens and the photosensitive chip are configured to be driven simultaneously and to move in opposite directions. Also provided in the present invention are a corresponding photographing method, an optically stabilizing photographing module, and a corresponding assembly method. The present application increases the stabilization travel and the stabilization response speed of the photographing module.

Abstract: A light-emitting device is provided. The light-emitting device generates a white light and includes at least one light-emitting diode. The at least one light-emitting diode generates a light beam with a broadband blue spectrum and includes a first semiconductor layer, a second semiconductor layer and a multiple quantum well structure. The multiple quantum well structure is located between the first semiconductor layer and the second semiconductor layer, and includes well layers and barrier layers. The well layers include a first well layer, a second well layer and third well layers different in indium concentrations. The first well layer has the largest indium concentration, and the third well layers have the smallest indium concentration. Three of the well layers that are closest to the first semiconductor layer are the third well layers, and the first well layer is closer to the second semiconductor layer than the first semiconductor layer.

Abstract: The present disclosure provides a method and a device for target identification, electric device, a storage medium, and a neuromodulation apparatus. The method for target identification includes: acquiring scanning data of a subject, wherein the scanning data include data acquired from magnetic resonance imaging of a brain of the subject; determining, based on the scanning data, at least two brain regions of the subject, each brain region including at least one voxel; determining, based on a disease type of the subject, at least one target brain region corresponding to the type of the disease in the at least two brain regions; and determining, based on a preset target identification rule, the at least one target located in the target brain region.

Abstract: There is provided a light emitting device for plant cultivation comprising: a broadband blue solid-state light source for generating broadband blue light with a maximum emission wavelength from 420 nm to 495 nm; wherein broadband blue solid-state light source generates blue light from 400 nm to 520 nm having an intensity wavelength spectrum which over a wavelength of at least 40 nm has an intensity that varies by less than 25%, less than 15%, or less than 10%; or from 430 nm to 470 nm or from 450 nm to 465 nm has an intensity that varies by less than 10%.

Abstract: A compound represented by formula (I) and a pharmaceutically acceptable salt thereof, as well as an antifungal application of the compound.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: Method and apparatus for determining a flip angle for multi-tissue magnetic resonance scanning. The method including: determining multiple types of tissue of interest for MRI this time; acquiring a relationship between combined SSI MR signal strength of all the tissues of interest and flip angle of an SSI sequence; acquiring a maximum value of the combined SSI MR signal strength of all the tissues of interest; according to the maximum value of the combined SSI MR signal strength of all the tissues of interest, acquiring an optimum flip angle which causes the combined SSI MR signal strength of all the tissues of interest and contrast between the tissues of interest simultaneously to be optimal; and taking the optimum flip angle to act as a flip angle of an SSI sequence for multi-tissue MR scanning this time.

Abstract: There is provided a light emitting device, for example a grow-light, comprising: a first solid-state light source that generates blue light with a blue photon flux; and a second solid-state light source that generates red light with a red photon flux; wherein a ratio of the blue photon flux to red photon flux is from about 1:3 to about 3:1. It may be that the broadband blue light substantially matches at least one of: the absorption peak wavelength of chlorophyll-a; the absorption peak wavelength of chlorophyll-b; and the absorption peak wavelength of carotenoid.

Abstract: Disclosed are a method and device for realizing advanced nitrogen removal of mature landfill leachate and sludge reduction by using sludge fermentation products as carbon source, belonging to the field of biological treatment of sludge of high ammonia nitrogen wastewater.

Abstract: The embodiment of the present disclosure discloses a method, an electronic device, and a storage medium for a ship route optimization. The method for the ship route optimization considers a dynamic feature of a multi-functional emergency rescue ship and an interference effect caused by an airflow, uses a movement model with kinematics non-holonomic constraints, such as a ship total cost assessment function to simulate the movement of the ship, and based on a sparrow search algorithm, learns how to apply the algorithm to a route plan of the emergency rescue ship. The method can improve the ship route optimization algorithm, improve an accuracy and practical applicability of a calculated plan. The method can effectively and accurately locate obstacles and hidden reefs, and consider effects of an airflow and a non-holonomic constraint effect, so as to make the route planning of the ship more efficient and intelligent.

Abstract: A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.

Abstract: A light-emitting module and a light-emitting diode are provided. The light-emitting diode includes an epitaxial light-emitting structure to generate a light beam with a broadband blue spectrum. A spectrum waveform of the broadband blue spectrum has a full width at half maximum (FWHM) larger than or equal to 30 nm. The spectrum waveform has a plurality of peak inflection points, and a difference between two wavelength values to which any two adjacent ones of the peak inflection points respectively correspond is less than or equal to 18 nm.

Abstract: Methods and systems are provided for sequence-to-sequence conversion from unstructured search queries to structured database queries, so that lay persons may retrieve information from relational databases without specialized knowledge of database query languages. An encoder module and a decoder module of a learning model are trained to convert an unstructured search query to an intermediate feature vector by computing co-attention and self-attention based on a context string and a database schema, encoding the database schema in the context string by application of self-attention between the context string containing tokens of the database schema with learned structural attention heads which relate the token to logic of the database. Training is performed using labeled training datasets which include structured database queries which are normalized by parsing into a semantic representation thereof, followed by linearization.

Abstract: The present disclosure provides a target identification method, a target identification device, an electronic apparatus, a storage medium and a neuromodulation apparatus. The target identification method includes: acquiring scan data of a subject, the scan data including data obtained from magnetic resonance imaging of the subject's brain; determining the corresponding relationship of regions of interest of a disease type of the subject according to the disease type of the subject; determining at least one disease region of interest and at least one target region of interest of the subject in the scan data according to the corresponding relationship of the regions of interest; determining connectivity between each of voxels in the target region of interest and each disease region of interest in the at least one disease region of interest; and determining the positions of the voxels with the connectivity meeting a preset target connectivity condition in the target region of interest as the targets.

Abstract: The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating LPA-associated diseases, disorders, and conditions.

Abstract: This disclosure relates to LPA antagonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.

Abstract: The present application relates to an optical image stabilization camera module, comprising: a lens; a photosensitive assembly having a photosensitive chip; a first driving part adapted to drive the lens to translate in x-axis and y-axis directions; and a second driving part comprising a second basic portion and a second movable portion, the second driving part having four side surfaces, wherein each side surface is provided with two interlaced SMA wires, and both ends of each SMA line are connected to a fixed end of the second basic portion and a fixed end of the second movable portion, respectively; each of the fixed ends is located at a corner area of the second basic portion or the second movable portion.

Abstract: The present invention is related to the inhibition of the formation of Streptococci biofilms through the inhibition of glucosyl transferase (Gtf). Compounds, compositions and methods for inhibiting Streptococcus biofilm formation, as well as for preventing, inhibiting and/or treating the formation of dental caries, and methods of identifying compounds that prevent, inhibit and/or treat the formation of dental caries are provided.